11:10-11:35

Abstract 4003

Phase III study of apatinib in advanced   gastric cancer: A randomized, double-blind, placebo- controlled trial.

阿帕替尼治疗晚期胃癌的随机、双盲、安慰剂对照的III期临床研究。

张小田(Xiao-Tian   Zhang)

Abstract 4005

RAINBOW: A global, phase III, randomized,   double-blind study of ramucirumab (RAM) plus paclitaxel (PTX) versus placebo   (PL) plus PTX in the treatment of metastatic gastroesophageal junction and   gastric adenocarcinoma (mGC) following disease progression on first-line   platinum- and fluoropyrimidine- containing combination therapy—Efficacy   analysis in Japanese and Western patient.

RAINBOW：一项ramucirumab（RAM）对比安慰剂联合紫杉醇治疗一线铂类／氟尿嘧啶失败的转移性胃食管结合部或胃腺癌的全球随机、双盲、III期研究——日本与西方人群的疗效分析。

Abstract 4008

Phase III trial to compare   capecitabine/cisplatin (XP) versus XP plus concurrent capecitabine-   radiotherapy in gastric cancer (GC): The final report on the ARTIST trial.

卡培他滨／顺铂（XP）对比XP联合卡陪他滨同步放疗治疗胃癌的III期研究：ARTIST的最终结果汇报。

11:35–11:45

专家评述

Discussion Topic: Anti-angiogenesis for gastric cancer

讨论主题：胃癌的抗血管生成治疗

郭伟剑(Wei-Jian   Guo)

11:45–11:50

讨论(Q &   A)

沈  琳(Lin Shen)

徐建明(Jian-Ming Xu)

郭伟剑(Wei-Jian Guo)